首页> 外文期刊>Journal of Immune Based Therapies Vaccines >Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)
【24h】

Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)

机译:鉴定树突状细胞在蛋白质纯化衍生物(PPD)加工中使用的蛋白酶

获取原文
           

摘要

Dendritic cells (DC) are known to present exogenous protein Ag effectively to T cells. In this study we sought to identify the proteases that DC employ during antigen processing. The murine epidermal-derived DC line Xs52, when pulsed with PPD, optimally activated the PPD-reactive Th1 clone LNC.2F1 as well as the Th2 clone LNC.4k1, and this activation was completely blocked by chloroquine pretreatment. These results validate the capacity of XS52 DC to digest PPD into immunogenic peptides inducing antigen specific T cell immune responses. XS52 DC, as well as splenic DC and DCs derived from bone marrow degraded standard substrates for cathepsins B, C, D/E, H, J, and L, tryptase, and chymases, indicating that DC express a variety of protease activities. Treatment of XS52 DC with pepstatin A, an inhibitor of aspartic acid proteases, completely abrogated their capacity to present native PPD, but not trypsin-digested PPD fragments to Th1 and Th2 cell clones. Pepstatin A also inhibited cathepsin D/E activity selectively among the XS52 DC-associated protease activities. On the other hand, inhibitors of serine proteases (dichloroisocoumarin, DCI) or of cystein proteases (E-64) did not impair XS52 DC presentation of PPD, nor did they inhibit cathepsin D/E activity. Finally, all tested DC populations (XS52 DC, splenic DC, and bone marrow-derived DC) constitutively expressed cathepsin D mRNA. These results suggest that DC primarily employ cathepsin D (and perhaps E) to digest PPD into antigenic peptides.
机译:已知树突状细胞(DC)可将外源蛋白Ag有效地呈递给T细胞。在这项研究中,我们试图确定抗原加工过程中DC所使用的蛋白酶。鼠表皮来源的DC线Xs52受到PPD脉冲时,可以最佳地激活PPD反应性Th1克隆LNC.2F1和Th2克隆LNC.4k1,并且这种激活被氯喹预处理完全阻断了。这些结果证实了XS52 DC将PPD消化成可诱导抗原特异性T细胞免疫应答的免疫原性肽的能力。 XS52 DC以及脾脏DC和DC衍生自骨髓,降解了组织蛋白酶B,C,D / E,H,J和L,类胰蛋白酶和乳糜酶的标准底物,表明DC表达了多种蛋白酶活性。用天冬氨酸蛋白酶的抑制剂胃蛋白酶抑制素A处理XS52 DC,完全消除了它们将天然PPD呈递给Th1和Th2细胞克隆的胰蛋白酶消化的PPD片段的能力。胃蛋白酶抑制素A还选择性抑制XS52 DC相关蛋白酶活性中的组织蛋白酶D / E活性。另一方面,丝氨酸蛋白酶的抑制剂(二氯异香豆素,DCI)或半胱氨酸蛋白酶的抑制剂(E-64)既不损害PPD的XS52 DC表现,也不抑制组织蛋白酶D / E活性。最后,所有测试的DC群体(XS52 DC,脾脏DC和骨髓来源的DC)组成性表达组织蛋白酶D mRNA。这些结果表明,DC主要利用组织蛋白酶D(可能还包括E)将PPD消化成抗原肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号